Evidence map›Paper›PMID 24251620›Full record

ArticleBritish journal of pharmacology2014

Structural requirements of steroidal agonists of transient receptor potential melastatin 3 (TRPM3) cation channels.

A Drews, F Mohr, O Rizun, T F J Wagner, S Dembla, S Rudolph, S Lambert, M Konrad, S E Philipp, M Behrendt and 3 more

Open access · hybridAbstract read
In one paragraph

Article in British journal of pharmacology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed
1.9field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 62 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Role of TRP Channels in Metabolism-Related Diseases.International journal of molecular sciences · 2024
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Neurosteroid enantiomers as potentially novel neurotherapeutics.Neuroscience and biobehavioral reviews · 2023
    Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Partial Agonistic Actions of Sex Hormone Steroids on TRPM3 Function.International journal of molecular sciences · 2021
    Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. TRPM3 in Brain (Patho)Physiology.Frontiers in cell and developmental biology · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 2 countries.

A DrewsExperimentelle und Klinische Pharmakologie und Toxikologie, Universität des Saarlandes, Homburg, Germany.
F Mohr
O Rizun
T F J Wagner
S Dembla
S Rudolph
S Lambert
M Konrad
S E Philipp
M Behrendt
S Marchais-Oberwinkler
D F Covey
J Oberwinkler
Philipps University of Marburg · DESaarland University · DEWashington University in St. Louis · US

Funding

STRUCTURE/ACTIVITY STUDIES OF NEUROSTEROID ANALOGUESP01GM047969 · NIGMS · WASHINGTON UNIVERSITY · PI COVEY, DOUGLAS F · 1992 to 2011
$18.7M
NIGMS NIH HHS GM47969NIGMS NIH HHS P01 GM047969
6 · The paper itself

Abstract

background and purposeTransient receptor potential melastatin 3 (TRPM3) proteins form non-selective but calcium-permeable membrane channels, rapidly activated by extracellular application of the steroid pregnenolone sulphate and the dihydropyridine nifedipine. Our aim was to characterize the steroid binding site by analysing the structural chemical requirements for TRPM3 activation. EXPERIMENTAL APPROACH: Whole-cell patch-clamp recordings and measurements of intracellular calcium concentrations were performed on HEK293 cells transfected with TRPM3 (or untransfected controls) during superfusion with pharmacological substances. KEY

resultsPregnenolone sulphate and nifedipine activated TRPM3 channels supra-additively over a wide concentration range. Other dihydropyridines inhibited TRPM3 channels. The natural enantiomer of pregnenolone sulphate was more efficient in activating TRPM3 channels than its synthetic mirror image. However, both enantiomers exerted very similar inhibitory effects on proton-activated outwardly rectifying anion channels. Epiallopregnanolone sulphate activated TRPM3 almost equally as well as pregnenolone sulphate. Exchanging the sulphate for other chemical moieties showed that a negative charge at this position is required for activating TRPM3 channels. CONCLUSIONS AND IMPLICATIONS: Our data demonstrate that nifedipine and pregnenolone sulphate act at different binding sites when activating TRPM3. The latter activates TRPM3 by binding to a chiral and thus proteinaceous binding site, as inferred from the differential effects of the enantiomers. The double bond between position C5 and C6 of pregnenolone sulphate is not strictly necessary for the activation of TRPM3 channels, but a negative charge at position C3 of the steroid is highly important. These results provide a solid basis for understanding mechanistically the rapid chemical activation of TRPM3 channels.

Indexed as

TRPM Cation ChannelsAnimalsBase SequenceBinding SitesHEK293 CellsHumansMiceMolecular Sequence DataNifedipinePregnenoloneNifedipinePregnenolonepregnenolone sulfateTRPM3 protein, mouseTRPM Cation Channelscation membrane channelClC-3dihydropyridineenantiomerneurosteroidPAORACpregnenolone sulphateproton-activated outwardly rectifying anion channeltransient receptor potentialtransient receptor potential melastatin

Identifiers

PMID24251620
PMCPMC3925040
OpenAlexW2094854629

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.